Increasing Inclination of Oncologists and Physician to opt for Non-Invasive Diagnostic Procedures is Anticipated to Propel the Growth of the Global Liquid Biopsy market
The Global Liquid Biopsy market is anticipated to upsurge at a high rate owing to the factors such as rising consumption of alcohol and tobacco products, increasing prevalence of cancer cases along with burgeoning preference for non-invasive procedures and escalating funding for liquid biopsy research and development. Moreover, snowballing funding by public and private companies to support research activities, surge in the clinical trials for the development of these tests coupled with robust changing lifestyle of people and increasing inclination of oncologists and physician to opt for non-invasive diagnostic procedures are projected to fuel the growth of the market in the forthcoming years. The COVID-19 pandemic has positive impact on the liquid biopsy market as it surged the demand for liquid biopsy test as it used to improve cancer screening along with introduction of commercialize saliva-based liquid biopsy tests for head and neck cancer, COVID-19. . Get a sample copy o...